Unclassified · Medical Literature

[Articles] Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

Authors: Walter Reinisch, David Stepek, Radoslaw Kempinski, Silvio Danese, Bruce E Sands, Bogdan Ratiu-Duma, Rajendra Singh, Phillip Levine, Hadas Barkay, Nicholas Gross, Ken Abrams, Vipul Jairath
Journal: The Lancet Gastroenterology & Hepatology
Publication date: 2026-07-16
Source: rss_lancet_gas
Original record ID: 210199
Summary status: error
Analysis status: error
Original last updated: 2026-08-10T07:01:43.000Z

Abstract

Duvakitug showed significant evidence for clinical remission versus placebo, with no safety concerns identified, in patients with moderately to severely active ulcerative colitis.